Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy | |
Wang Bojun[1]; Tian Tian[2]; Kalland Karl-Henning[3]; Ke Xisong[4]; Qu Yi[5] | |
刊名 | Trends in pharmacological sciences |
2018 | |
卷号 | 39页码:648-658 |
关键词 | Wnt cancer combination therapy immunotherapy resistance β-catenin |
ISSN号 | 1873-3735 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2181013 |
专题 | 上海大学 |
作者单位 | 1.[1]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 2.These authors contributed equally to the manuscript. 3.[2]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China 4.These authors contributed equally to the manuscript. 5.[3]Department of Clinical Science, University of Bergen, Bergen, Norway. 6.[4]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. Electronic address: xisongke@shutcm.edu.cn. 7.[5]Innovation Center of Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, P.R. China. Electronic address: yiqu@shutcm.edu.cn. |
推荐引用方式 GB/T 7714 | Wang Bojun[1],Tian Tian[2],Kalland Karl-Henning[3],et al. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy[J]. Trends in pharmacological sciences,2018,39:648-658. |
APA | Wang Bojun[1],Tian Tian[2],Kalland Karl-Henning[3],Ke Xisong[4],&Qu Yi[5].(2018).Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.Trends in pharmacological sciences,39,648-658. |
MLA | Wang Bojun[1],et al."Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy".Trends in pharmacological sciences 39(2018):648-658. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论